rheumatoid arthritis

February 16, 2015February 16, 2015

Amgen Anticipates FDA Approval of Adalimumab Biosimilar For RA Based on Positive Phase III Results

Amgen has announced encouraging results from a Phase 3 study designed to assess its biosimilar candidate ABP 501 in patients who suffer from moderate to severe rheumatoid arthritis. The research was designed to evaluate the efficacy ... Read more

February 13, 2015February 13, 2015

ANI Pharmaceuticals Launches Etodolac Capsules for Rheumatoid and Osteoarthritis

News, rheumatoid arthritis

Emerging generic pharmaceutical company, ANI Pharmaceuticals, Inc. is going to launch a new drug for the management of the symptoms and signs of both rheumatoid arthritis and osteoarthritis, as well as acute pain. ... Read more

February 12, 2015February 12, 2015

Free Seminar Offers Info on Stem Cell Treatment Options For RA, Other Chronic Diseases

News, rheumatoid arthritis

The Miami Stem Cell Treatment Center recently announced a series of free public seminars on the use of adult autologous stem cells to address inflammatory and degenerative conditions, which will be offered in February and March. The ... Read more

February 11, 2015February 11, 2015

New Systematic Review Analyzes Effects of Exercise on Depression in Adults With Various Forms of Arthritis

News, rheumatoid arthritis

A recent study entitled “Effects of exercise on depression in adults with arthritis: a systematic review with meta-analysis of randomized controlled trials” suggests that exercise activity can improve depression symptoms ... Read more

February 10, 2015February 10, 2015

Chikungunya May Mislead Rheumatoid Arthritis Diagnoses

News, rheumatoid arthritis

An infection with the Chikungunya virus presents several clinical similarities with rheumatoid arthritis that may lead to inaccurate diagnoses. A new study entitled “Chikungunya viral arthritis in the United States: A mimic of ... Read more

February 9, 2015February 9, 2015

Xencor’s Experimental Rheumatoid Arthritis Therapy Shows Promise, Preliminary Results Show

News, rheumatoid arthritis

Xencor, Inc., a biopharmaceutical company that specializes in developing monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer recently announced the preliminary results of their Phase ... Read more

January 23, 2015January 23, 2015

Reducing Abatacept Dose in Early RA Does Not Affect Remission

News, rheumatoid arthritis

A new study on rheumatoid arthritis entitled “Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis” ... Read more

January 22, 2015January 22, 2015

Rheumatoid Arthritis Treatment and Progression Affected by Socioeconomic Status

News, rheumatoid arthritis

A Canadian study on rheumatoid arthritis (RA) revealed the influence of clinical and socioeconomic variables in the discontinuation of biologic therapy by RA patients. The study entitled “Biologic Discontinuation in ... Read more

January 16, 2015January 16, 2015

Lower Socioeconomic Status Associated With Rheumatoid Arthritis Treatment Delay, Study Shows

News, rheumatoid arthritis

A new study entitled “Association of Socioeconomic Status with Treatment Delays, Disease Activity, Joint Damage and Disability in Rheumatoid Arthritis” was published in Arthritis Care & Research by Emily Molina ... Read more